Medela and Stryker's Neurovascular division are partnering to bring a new medical vacuum technology to stroke patients worldwide.
Introduction
Carbon monoxide (CO) is a colourless, odourless and tasteless gas resulting from the incomplete burning of carbon-containing substances due to insufficient oxygen supply to enable complete oxidation to carbon dioxide. CO exposure represents an important health issue since this gas is toxic and it can kill in the case of exposure to high levels.
Accidental CO exposure is usually from car exhaust, boilers, central heating systems or cookers; other possible causes of CO exposure include blocked chimneys or burning fuel in an enclosed or unventilated space.
In Australia and in several Asian countries, however, CO accidental exposure accounts for less than 10% of emergency calls about CO poisoning, the wide majority resulting from voluntary suicidal exposure, usually by charcoal burning or car exhausting.
CO poisoning occurs in the case of inhalation of high levels of CO and it represents a common cause of poisoning worldwide with an estimated 50,000 annual exposures in the USA. Every year in the UK more than 200 people are admitted to hospital with carbon monoxide poisoning, which leads to about 50 deaths per year.
CO toxicity primarily depends on impaired oxygen transport by haemoglobin as CO binds to haemoglobin 230-270 times more avidly than oxygen, thus leading to formation of carboxyhaemoglobin (COHb); as COHb cannot carry oxygen, this causes tissue hypoxia. 1 Moreover, CO binds to cytochrome c oxidase, resulting in impairment of adenosine triphosphate synthesis and inhibition of mitochondrial metabolism, leading to cellular respiratory dysfunction.
Other mechanisms of damage include plateletto-neutrophil aggregation and neutrophil degranulation, leading to release of myeloperoxidase, resulting in oxidative stress and apoptosis.
A theory regarding catecholamine crisis was recently suggested as a novel underlying pathophysiological mechanism in acute CO poisoning. According to this theory, CO-associated hypoxia causes an increase of dopamine and a decrease of dopamine turnover rates. 2 Dopamine excess, during the acute phase of CO intoxication, could be a major contributor to neurotoxicity.
CO presents an affinity for myoglobin about 60 times greater than that of oxygen; CO bound to myoglobin causes reduced cardiac output and hypotension, which may result in brain ischaemia.
Organs with the highest oxygen requirement are the most susceptible to damage; in fact brain and cardiac effects dominate clinical features.
Clinical presentation of CO poisoning strongly depends on levels of exposure. A tension-type headache is the most common symptom of mild poisoning; other symptoms include flu-like effects, dizziness, nausea and vomiting, confusion, stomach pain, shortness of breath and subtle cognitive impairment.
Long-term exposure to low levels of CO can also lead to neurological symptoms, such as difficulty in concentration and frequent emotional changes.
Patients with severe intoxication typically demonstrate impaired mental state and personality changes, vertigo, ataxia, tachycardia, chest pain caused by angina, seizures and also loss of consciousness, coma and death.
Some patients who survive the condition of acute CO intoxication may develop neuropsychiatric sequelae in the following weeks, usually within one month.
These sequelae vary widely and are estimated to occur in up to two-thirds of patients. 3, 4 Delayed neurological syndrome (DNS) is characterized by acute onset of neuropsychiatric, behavioural symptoms and motor dysfunction 5 after a lucid interval that ranges from two to 40 days. Patients may present confusion, urinary incontinence, emotional disorders, gait disturbances and, in rare cases, Parkinsonism and dementia with subacute onset. 6 DNS can follow any event causing a prolonged cerebral hypo-oxygenation and is usually preceded by a period of unconsciousness; nevertheless about 10% of cases associated with CO poisoning may not present loss of consciousness.
The mechanism responsible for neurological delayed effects seems to be related to chemical mediators leading to brain lipid peroxidation, which causes delayed reversible demyelinization of cerebral white matter, known as Grinker myelinopathy. 4 Identification of patients at risk of developing DNS plays an important role in the setting of these patients. Today, the best identified risk factors for long-term neurological effects are early and obvious neurological damage and a sustained loss of consciousness during CO exposure. 3 A retrospective cohort study divided 79 consecutive patients treated for CO poisoning after attempting suicide into a group of 66 patients who did not develop DNS and a group of 13 who did, comparing the two groups in terms of different items, in order to find predictors for developing DNS after CO poisoning.
Results showed that more severe consciousness disturbance at time of hospital admittance, positive computed tomography (CT) findings of diffuse white matter involvement, abnormally high CKMB and LDH enzyme levels and aging could be considered as risk factors for developing DNS. 7 It is interesting to note that the non-DNS developing group had a higher mean COHb level than the other group.
Recently, neuron-specific enolase, a glycolytic enzyme localized primarily to the neuronal cytoplasm and S100B, a calcium-binding protein localized to astroglial cells, showed a promising role as a marker of brain injury. In particular a serum S100B of more than 0.165 mg/l predicted DNS with a sensitivity of 90% and a specificity of 87%. 3, 8 DNS can improve within 1-2 years in approximately 60-70% of patients; 4 the possibility of full recovery appears to be inversely related with age. 9 CO poisoning and cerebral ischaemia: pathophysiology and possible therapeutic approaches A complex and, in a sense, controversial association is present between CO poisoning and brain ischaemia.
An increase in blood level of COHb, as we mentioned above, leads to hypoxia, brain oedema and neuronal cell death.
Moreover a recent study comparing a CO-poisoning cohort with a control cohort without CO exposure has demonstrated that long-term risk of ischaemic stroke is nearly 2.5-fold greater in the first group; 10 however, the mechanisms are still widely unclear.
On the contrary, we now know that CO is produced in every cell of healthy subjects by enzymes known as the heme oxygenases, which act on heme substrate to originate ferrous iron, biliverdin and CO.
There are two isoforms of this enzyme: HO-1, inducible, presenting a low basal activity in brain but highly induced in condition of stress (i.e. ischaemia), and HO-2, constitutive and highly expressed in brain.
It has been demonstrated that, in mice, inhalation of low-concentration CO (250 ppm for 18 h immediately after middle cerebral artery occlusion) is neuroprotective in the early stages of reperfusion after ischaemic stroke, significantly reducing the infarct size, even if no significant effects on behavioural deficits are observed. 10 This neuroprotective effect depends on the up-regulation of the Nrf2 pathway, Nrf2 being a transcriptional factor, considered to be a multi-organ protector for its antioxidant effects.
This protective effect was in fact absent in mice deficient in Nrf2.
The time window for CO administration appears to be a crucial aspect for its biological effect that still has to be elucidated. [11] [12] [13] Nowadays, treatment of patients with CO poisoning is primarily supportive, with administration of highflow oxygen. In the acute phase, the principal treatments for CO poisoning are high-flow oxygen treatment or hyperbaric oxygen therapy (HBOT); the latter is often recommended for patients showing loss of consciousness in severe poisoning. HBOT facilitates oxygen transport to tissues and it is currently known as the most common method for treating CO poisoning. 14 HBOT is warranted for patients with serious intoxication, loss of consciousness, neurological deficits, significant metabolic acidosis and COHb levels higher than 25%. Nevertheless its use is controversial due to insufficient evidences of efficacy and, as hypoxic stress is not the only pathophysiologic mechanism in CO poisoning, its role is likely over-rated. 15 Its therapeutic effect may be enhanced if combined with other treatments.
In recent years a therapeutic role of HBOT in ischaemic stroke has been postulated.
A prospective study, in particular, demonstrated a better clinical outcome in patients with mild disability after acute ischaemic stroke who received HBOT for two weeks, within 3-5 days after stroke onset, than in patients who received only conventional antiplatelet therapy. 16 The therapeutic role of HBOT could depend on the improvement of cerebral blood flow, on the promotion of collateral circulation and on its anti-inflammatory and anti-apoptotic properties.
It is generally acknowledged that HBOT seems to be more efficient the sooner it is applied but currently its effectiveness in the treatment of acute ischaemic stroke still has to be elucidated. 17 Targeted temperature management with mild therapeutic hypothermia seems to represent a promising treatment for CO poisoning. Also, based on the catecholamine crisis theory, administration of sympatholytics such as dexmethetomidine or remifentanil may be beneficial in preventing dopamine excess. 15 Corticosteroid therapy plays a role in the treatment of delayed leukoencephalopathy as this phenomenon depends on ischaemic changes but also demyelination and inflammation involving myelin basic protein; therefore it is reasonable to administer corticosteroid pulse therapy. 17 Treatment of CO poisoning, however, still remains controversial.
Role of neuroimaging
Neuroimaging plays an important role in the study of this entity both in the acute phase, to confirm the clinical diagnosis and provide prompt treatment, and in the chronic phase to evaluate possible neurological sequelae, since neuroimaging shows correlation with clinical outcome of these patients.
CT-scan of the brain is a very fast and widely available examination and, for these reasons, it represents in most cases the first examination performed in these patients.
CT-scan in the acute phase of CO poisoning typically demonstrates focal, bilateral and symmetrical hypodensities affecting the globus pallidus, as a result of necrosis of these structures. Selective damage of globus pallidus in CO poisoning could depend on the hypotensive effects of CO on the poor anastomotic vascular supply of these structures, or on a direct binding of CO to the heme iron in the globus pallidus, one of the regions of the brain with the highest iron content. 4 In rare cases, the globus pallidus could be spared, and involvement of the caudate nucleus, putamen or thalamus could be observed. Involvement of the cerebellum or brainstem in the acute phase is rare and it seems to reflect a more severe poisoning, since these posterior structures are more resistant to hypoxia. Cortical involvement in the acute phase is far less frequent and, if present, usually involves the temporal lobe and hippocampus.
Magnetic resonance imaging (MRI) can be useful in the acute phase to depict the pathological findings of this disease, showing altered signal intensity areas involving the globus pallidus bilaterally, which will result hypointense in T1-w sequences and hyperintense in T2-w and FLAIR sequences. 18 Diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADC) maps often show areas of restricted diffusivity in the globus pallidus, as for cytotoxic oedema. 19 In a subsequent phase, CT examination may show diffuse hypodense areas in the bilateral periventricular white matter and centrum semiovale as a result of extensive demyelination. In more severe cases, this process can extend to involve the internal and external capsules, corpus callosum and subcortical white matter.
In this phase MRI can better depict the real extent of the demyelinating process, revealing areas of hypointensity in T1-w images and hyperintensity in T2-w and FLAIR sequences in the bilateral white matter, partially confluent. DWI and ADC maps usually reveal in these areas restriction in water diffusivity referable to cytotoxic oedema and demyelination. 20 CT and MRI findings of chronic phase CO poisoning are represented by brain atrophy, depicted as areas of sulcal widening and increased ventricle-to-brain ratio.
Emergency management
In the case of clinical suspicion of acute CO poisoning, immediate and direct assessment of the respiratory and circulatory status of the patient should be performed. Intubation should be considered if respiratory distress, stridor or hypoventilation are present, in order to obtain adequate airway protection and ventilation. CO exposure can cause cardiac injury, therefore cardiovascular investigations including electrocardiograms and measurement of cardiac enzymes (troponin and CK-MB) is required. 21 COHb levels in arterial blood should be measured to confirm the diagnosis. If diagnosis is confirmed, treatment with normobaric or hyperbaric high-flow oxygen, mainly depending on COHb levels, should be started (Figure 1) .
It is important to ensure that the patient is resting in order to decrease the oxygen demand.
However, the COHb level at which hyperbaric oxygen therapy should be performed is controversial.
Methodology
A comprehensive review of the literature was performed using Pubmed and Medline databases, typing the keywords 'CO brain poisoning', 'CO brain neuroimaging', 'CO poisoning MRI', 'CO poisoning, ischaemic stroke' and 'CO poisoning therapy'.
Review articles from the last 15 years were preferred.
Discussion of issues
Most of these articles highlight the role of neuroimaging to perform prompt diagnosis of CO brain poisoning.
CT is considered as a first step technique in the evaluation of patients with suspicion of poisoning; it is particularly useful in the case of loss of consciousness.
Its main limitation depends on the difficulty of evaluating the real extent of the white matter impairment, which, according to many authors, correlates with prognosis in these patients. 4 MRI is a second step technique that has been performed in the evaluation of this condition since the end of the 1980s. MRI is more sensitive than CT in assessing the extent of involvement of the white matter, which, according to many reports, closely relates with prognosis.
Moreover, DWI imaging with corresponding ADC maps represents nowadays a fundamental diagnostic tool to evaluate cytotoxic oedema and, in subacute and chronic phases, progressive demyelination, responsible for the development of delayed neurological sequelae.
It is important to highlight that DWI positivity persists even for some months differently from cytotoxic oedema, which usually resolves in about four weeks.
Functional MR techniques have been developed in recent years in order to obtain further diagnostic and prognostic information.
MR spectroscopy (MRS) enables non-invasive monitoring of metabolic changes in brain tissue. This technique could play an important role in the diagnosis and follow-up of this entity.
An increase in choline (Cho) levels and of the Cho/ creatine (Cr) ratio reflects active membrane metabolism associated with several pathological conditions such as degeneration and gliosis. From three to four weeks after clinical onset, moreover, a decrease of the N-acetylaspartate (NAA)/Cr ratio can be observed as a result of neuronal loss. It is noteworthy that reductions in NAA levels have been proposed as a good prognostic factor, as the NAA/Cr ratio correlates with symptoms development. 4 The presence of lactate represents anaerobic glycolysis under ischaemic or hypoxic conditions. Lactate began to appear at the earliest from one to two months after CO poisoning. Its presence is considered as a marker of irreversible brain damage because it has been observed in patients with severe chronic symptoms. However, even though MRS provides valuable information on brain metabolism in patients with delayed encephalopathy after acute CO exposure, long-term outcome is still complicated since patients with severe, initial MRS measurements may show reversibility; 22 hence a careful and accurate follow-up of these patients appears to be crucial.
Diffusion tensor imaging (DTI) has been applied to evaluate CO poisoning since 2005. DTI evaluates the directionality of water diffusion in cerebral tissue. Normal white matter tracts show a higher degree of fractional anisotropy since the tracts are highly directional. On the contrary, if myelination is compromised, fractional anisotropy values are expected to decrease. 23 DTI can provide a quantitative assessment of the degree of demyelination and it could offer a predictor for the development of DNS. Moreover, longitudinal assessment of DTI parameters could be very useful to evaluate the efficacy of treatments. 24 The main limitation of MRI is its being time-consuming and difficult to perform in uncooperative patients. examination, particularly if loss of consciousness is present.
After that, an MRI examination should be performed to confirm CT findings and to obtain a detailed assessment of the white matter. DWI with ADC maps represents nowadays a fundamental tool to clarify the extent of brain injury and to provide further diagnostic and prognostic information. MRS and DTI represent promising techniques to identify patients at higher risk of developing DNS or presenting more severe demyelination.
It is difficult to define a standardized follow-up imaging protocol since the pathogenesis of DNS has not been delineated fully.
However, a closer follow-up is recommended for patients presenting a more severe onset with prolonged loss of consciousness, who are elderly and with diffuse white matter damage, who are considered to be at higher risk of developing DNS.
Teaching points
CO poisoning is the most common cause of fatal poisoning worldwide.
Neuroimaging plays a fundamental role in the diagnosis and prognosis of this disease both in the acute and in the chronic phase.
A consistent number of patients presenting brain CO poisoning (up to two-thirds) will suffer a delayed leukoencephalopathy with acute clinical onset of neurological and neuropsychiatric symptoms after a lucid interval of 2-40 days.
A controversial association is present between CO poisoning and brain ischaemia since a recent study demonstrated a 2.5-fold greater incidence of ischaemic stroke in a CO-poisoning cohort than in a control cohort without CO exposure.
It is time to reconsider the new role of CO, since CO has been demonstrated to be a neuroprotective agent 
